The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2022 for the Tribal Opioid Response grants.
Donor Name: Substance Abuse and Mental Health Services Administration (SAMHSA)
State: All States
County: All Counties
Type of Grant: Grant
Deadline (mm/dd/yyyy): 06/27/2022
Size of the Grant: $1,925,000
Grant Duration: 2 years
Details:
The purpose of the TOR program is to assist in addressing the overdose crisis in Tribal communities by increasing access to FDA-approved medications for the treatment of opioid use disorder (MOUD), and supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and co-occurring substance use disorders. The TOR program also supports the full continuum of prevention, harm reduction, treatment, and recovery support services for stimulant misuse and use disorders, including for cocaine and methamphetamine.
Funding Information
- Estimated Total Available Funding: Up to $55,000,000.
- Award Ceiling: $1,925,000.
Grant Period
- Length of Project Period: Up to 2 years
Allowable Activities
Allowable activities are an allowable use of grant funds but are not required. Recipients may use grant funds to provide any allowable activity if it does not interfere or prevent the grant recipient from performing all required activities and serving the total number of unduplicated individuals each year of the grant. Allowable activities may include:
- Complete a community readiness or needs assessment, and a comprehensive strategic plan, based on the most current epidemiological data for the Tribe to address the gaps in prevention, treatment, and recovery support services identified by the Tribe.
- Implement workforce development activities to ensure that individuals working in tribal communities are well versed in strategies to prevent and treat opioid misuse. Grant recipients are encouraged to assist eligible practitioners with the process of obtaining a DATA waiver for prescribing buprenorphine medications for the treatment of OUD.
- Incorporate culturally appropriate and traditional practices into the program design and implementation.
- Develop and implement evidence-based contingency management programs to treat stimulant use disorder and concurrent substance misuse, and to also improve retention in care.
- Provide assistance to patients with treatment costs and develop other strategies to eliminate or reduce treatment costs for under- and uninsured patients. Grant recipients may provide cost assistance to clients for transportation, childcare, and other supportive services.
- Address barriers to receiving MOUD by reducing the cost of treatment, developing innovative systems of care to expand access to treatment, engaging and retain patients in treatment, address discrimination associated with accessing treatment, including discrimination that limits access to MOUD, and support long-term recovery.
- Provide treatment transition and coverage for patients reentering communities from criminal justice settings or other rehabilitative settings.
- Purchase and/or implement mobile and/or non-mobile medication units that provide appropriate privacy and adequate space to administer and dispense medications for OUD treatment in accordance with federal regulations.
- The following services may be provided in mobile medication units, assuming compliance with all applicable federal, state, and local law:
- Administering and dispensing medications for opioid use disorder treatment.
- Collecting samples for drug testing or analysis.
- Dispensing of take-home medications.
- In units that provide appropriate privacy and adequate space, conduct intake/initial psychosocial and appropriate medical assessments (with a full physical examination to be completed or provided within 14-days of admission).
- Initiating methadone or buprenorphine after an appropriate medical assessment has been performed.
- In units that provide appropriate privacy and have adequate space, other services, such as counseling, may be provided directly or when permissible through use of telehealth services. Non-mobile medication units may also offer the above services where space allows for quality patient care and are consistent with state and local laws and regulations
- Support education, screening, care coordination, risk reduction interventions, testing, and counseling for HIV/AIDS, hepatitis, and other infectious diseases.
- Support innovative telehealth strategies to increase the capacity of tribal communities to support OUD/stimulant use disorder prevention, treatment, and recovery
- Develop and implement tobacco/nicotine product (e.g., vaping) cessation programs, activities, and/or strategies.
- Assess the impact of the grant. (Consider working with Tribal Epidemiology Centers or an Evaluator to implement this activity. However, including an Evaluator in the staffing component is not required).
- Provide cultural competency and implicit bias reduction training to service providers to increase awareness and acknowledgment of differences in language, age, culture, socio-economic status, political and religious beliefs, sexual orientation and gender identity, and life experiences.
- Provide activities that address behavioral health disparities and the social determinants of health.
Eligibility Criteria
- Federally-recognized Tribes and tribal organizations. Tribes and tribal organizations may elect to apply as part of a consortium or in partnership with Urban Indian Organizations. Tribes and tribal organizations may only be included in one grant application.
For more information, visit Grants.gov.
